FABHALTA vs SOLIRIS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. FABHALTA and SOLIRIS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	FABHALTA	SOLIRIS
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	IPTACOPAN HYDROCHLORIDE	ECULIZUMAB
Manufacturer	Novartis	Alexion Pharm
Dosage forms	Capsule	Injectable
Drug class	—	Complement Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Paroxysmal Hemoglobinuria	Paroxysmal Hemoglobinuria, Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome

fabhalta soliris

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

IPTACOPAN HYDROCHLORIDE

ECULIZUMAB

Manufacturer

Novartis

Alexion Pharm

Dosage forms

Capsule

Injectable

Drug class

—

Complement Inhibitor

Boxed warning

Treats

Paroxysmal Hemoglobinuria

Paroxysmal Hemoglobinuria, Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome

Frequently asked questions

Which is better-rated, Fabhalta or Soliris?

Fabhalta and Soliris are tied at 3.5 out of 5 by our independent rating.

What is the difference between Fabhalta and Soliris?

Fabhalta contains Iptacopan Hydrochloride, while Soliris contains Eculizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.